SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ørsted A/S (DOGEF) trades at a trailing P/E of 13.5, forward P/E of 3.0. Trailing earnings yield is 7.43%, forward earnings yield 33.44%. PEG 0.01 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (13.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.01); earnings yield beats bond yields (7.43%).
- Forward P/E 3.0 (down from trailing 13.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 7.43% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 33.44% as earnings recover.
Overall SharesGrow Score: 50/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DOGEF
Valuation Multiples
P/E (TTM)13.5
Forward P/E3.0
PEG Ratio0.01
Forward PEG0.01
P/B Ratio0.00
P/S Ratio0.36
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.94
Forward EPS (Est.)$8.72
Book Value / Share$0.00
Revenue / Share$71.62
FCF / Share$0.00
Yields & Fair Value
Earnings Yield7.43%
Forward Earnings Yield33.44%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$18.10 |
$57.39B |
$7.55B |
13.1% |
| 2017 |
$44.50 |
$59.71B |
$18.72B |
31.4% |
| 2018 |
$42.38 |
$68.65B |
$17.83B |
26% |
| 2019 |
$15.47 |
$59.34B |
$6.51B |
11% |
| 2020 |
$35.95 |
$37.1B |
$15.6B |
42% |
| 2021 |
$24.32 |
$69.14B |
$10.96B |
15.9% |
| 2022 |
$34.60 |
$126.09B |
$15.13B |
12% |
| 2023 |
$-50.08 |
$79.26B |
$-20.51B |
-25.9% |
| 2024 |
$-2.20 |
$58.83B |
$-206M |
-0.4% |
| 2025 |
$1.94 |
$63.46B |
$1.72B |
2.7% |
